On Thursday, Shares of Opko Health Inc. (NYSE:OPK), gained 2.54% to $9.28.
Cocrystal Pharma, declared that its late-breaking abstract was accepted for a poster presentation at The Liver Meeting, the annual meeting of the American Association of the Study of Liver Diseases (AASLD) in San Francisco, November 13-17. The abstract, entitled, “Preclinical characterization of CC-31244, a potent, pan-genotypic nonnucleoside NS5B polymerase inhibitor (NNI) for the treatment of chronic hepatitis C”, will be presented by Dr. Sam Lee, President, on Monday the 16th at 12:30 pm. The abstract is available after October 20th at www.aasld.org/.
In the abstract, Cocrystal revealed the genotype coverage, in vitro and preclinical properties of a novel NNI inhibitor, CC-31244
“We are encouraged by the CC-31244 preclinical profile and the opportunity to develop a novel, pan-genotypic NNI. Cocrystal is working to transition into a clinical company and excited about the numerous antiviral programs we are presently developing,” said Dr. Douglas Mayers, Cocrystal Pharma Chief Medical Officer.
OPKO Health, Inc., a biopharmaceutical and diagnostics company, engages in the discovery, development, and commercialization of novel and proprietary technologies in the United States and internationally.
Shares of Mylan NV (NASDAQ:MYL), inclined 1.16% to $42.73, during its last trading session.
Mylan, will at 5:00 p.m. ET host a conference call and webcast to review the clear value to be created for Perrigo Company plc (NYSE: PRGO; TASE) shareholders through Mylan’s offer to acquire the company. The call will be hosted by Mylan’s Executive Chairman Robert J. Coury, CEO Heather Bresch and CFO John Sheehan.
Mylan N.V., through its auxiliaries, develops, licenses, manufactures, markets, and distributes generic, branded generic, and specialty pharmaceuticals worldwide. The company provides generic or branded generic pharmaceutical products in tablet, capsule, injectable, or transdermal patch forms, in addition to active pharmaceutical ingredients (APIs).
Finally, GoPro Inc (NASDAQ:GPRO), ended its last trade with 1.60% gain, and closed at $28.54.
GoPro, declared the University of Southern California School of Cinematic Arts (SCA) is a flagship partner in the creative community as it kicks off GoPro Awards. Declared yesterday, GoPro Awards is GoPro’s always-on content platform that rewards the GoPro community for sharing their best GoPro photos, raw video clips and video edits for inclusion in GoPro Channel programming, licensing and more. As part of the program with USC, GoPro offered cameras and accessories to film school students and will start guided workshops, education and one-on-one mentorship this fall.
“As user generated content evolves into mainstream entertainment, GoPro wants to work with the best creators in the world to enable high quality, sophisticated storytelling,” said Zander Lurie, SVP of Entertainment at GoPro. “Our program with universities such as USC’s School of Cinematic Arts is one of the best ways to achieve that aim. We’re excited to see the great things students will create with the assist of GoPro and we hope some of them will even join the GoPro team and work with us someday.”
Together at USC earlier recently, GoPro CEO Nick Woodman and USC’s Dean Elizabeth Daley declared this unique partnership before a live audience of GoPro employees, USC’s Cinematic Arts students, alumni and friends. In addition to the camera donation and workshops, it was declared that GoPro will showcase top talent from USC on its GoPro Awards platform and students will also be eligible to receive monetary rewards through the program.
GoPro, Inc. develops hardware and software solutions to alleviate consumer pain points associated with capturing, managing, sharing, and enjoying engaging content. The company offers HERO line of capture devices, such as cameras; premium accessories, counting battery BacPac, smart remote, and LCD touch BacPac accessories; and mounts comprising equipment-based mounts comprising of helmet, handlebar, roll bar, and grip and tripod mounts that enable consumers to capture content while engaged in a range of activities, in addition to mounts that enable customers to wear the mount on their bodies, such as wrist housings, chest harnesses, and head straps.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
